154 related articles for article (PubMed ID: 28986753)
1. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1.
Fanfone D; Despretz N; Stanicki D; Rubio-Magnieto J; Fossépré M; Surin M; Rorive S; Salmon I; Vander Elst L; Laurent S; Muller RN; Saussez S; Burtea C
Med Oncol; 2017 Oct; 34(11):184. PubMed ID: 28986753
[TBL] [Abstract][Full Text] [Related]
2. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes.
Fanfone D; Stanicki D; Nonclercq D; Port M; Vander Elst L; Laurent S; Muller RN; Saussez S; Burtea C
Biology (Basel); 2020 Mar; 9(3):. PubMed ID: 32183292
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
6. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
7. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.
Lin CI; Whang EE; Donner DB; Jiang X; Price BD; Carothers AM; Delaine T; Leffler H; Nilsson UJ; Nose V; Moore FD; Ruan DT
Mol Cancer Res; 2009 Oct; 7(10):1655-62. PubMed ID: 19825987
[TBL] [Abstract][Full Text] [Related]
11. New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer.
Gheysen L; Soumoy L; Trelcat A; Verset L; Journe F; Saussez S
Cells; 2021 May; 10(5):. PubMed ID: 34063063
[TBL] [Abstract][Full Text] [Related]
12. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
[TBL] [Abstract][Full Text] [Related]
13. Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium.
Burtea C; Laurent S; Sanli T; Fanfone D; Devalckeneer A; Sauvage S; Beckers MC; Rorive S; Salmon I; Vander Elst L; Lauwerys BR; Muller RN
Arthritis Res Ther; 2016 Oct; 18(1):230. PubMed ID: 27729062
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
Lu L; Jie L; Zhou Y; Zhang J; Feng T; Zhu Y; Chen T; Zhu X; Ji J; Wang Z
Curr Pharm Des; 2023; 29(9):686-696. PubMed ID: 36967466
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
[TBL] [Abstract][Full Text] [Related]
18. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma.
Ma J; Wang Y; Xi X; Tang J; Wang L; Wang L; Wang D; Liang X; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1052862. PubMed ID: 36936158
[TBL] [Abstract][Full Text] [Related]
20. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
